Washington Watch
Latest in Washington Watch
Compounders only have 2 to 3 months left to copy injectable
Response rate of 70% at day 28 with remestemcel-L
In randomized study, ensartinib doubled PFS versus first-generation ALK inhibitor
Spending reached $4.9 trillion, with spending on physician and clinical services up 7.4%
In randomized study, ensartinib doubled PFS versus first-generation ALK inhibitor
Spending reached $4.9 trillion, with spending on physician and clinical services up 7.4%
More in Washington Watch
South Carolina governor says that any public money "results in the subsidy of abortion"
Agreement would reduce a 2.8% cut to 0.3%, but doesn't include prior authorization reform
The warning highlights known risk of rare but serious liver injury associated with fezolinetant
Crinecerfont reduces excessive adrenal androgen production, lowering glucocorticoid dose